Top Eco-Toxicologist and Entomologist

A Top Scientist Joined GeneHarmonics Project 

GeneHarmonics Inc., the parent company of NanoHarmonics, as one of the participants in the population study that is aimed at developing datapoints to create predictive models to help fight future pandemics and present-day infectious diseases, started collaborations with John Stark, PhD of Washington State Academy of Sciences. John Stark is the premier eco-toxicologist and entomologist in the whole world.

“John is also a population modeler and has developed population-level risk assessments based on matrix models and differential equation models.” John shall design the population study to take into account several data points: levels and types of insecticides before, during, and after the study, behavior of disease-carrying insects, biomarkers in large swaths of populations before, during, and after the application of mitigation measures such as anti-insect paints as well as other products that can add an additional layer of protection for families that are applicable at the industrial scale.

The study shall be integrated by the data platform currently being developed by BitHarmonics, Inc., the data company of GeneHarmonics, Inc

In the picture (from left to right) are Dr. John Stark, Dr. Ray Brewer, an associate of Justin Jones, Justin Jones of NanoHarmonics Inc., and Zak Kennedy – during the groups visit in Washington State with Jaime Sta. Maria, founder and CEO of GeneHarmonics, BitHarmonics, and NanoHarmonics, Inc., to launch the project.

The population study is expected to the first in a series of studies that will be conducted to map out datapoints on other infectious diseases in other countries – Tuberculosis, Zika, Ebola and more.

The study has commitments from international organizations who will lead their expertise to help saves lives. Among them are:

  • ManpowerGroups Philippines who will organize and provide data collection human resources on the ground. Future studies shall be referred to by the Philippine office to other MPG offices in other countries. MPG is present in more than 70 countries around the world.
  • AADC (Agri-aqua development coalition) who will spearhead operationalization at the grassroots level as well as handle coordination works with local governments. AADC has strong affiliations with NGOs in more than 100 countries.
  • One of the major US Universities that specializing in ushering in future technologies in medical science.
  • Two of the leading research and science advocacy groups leading the fight against Malaria.

We have the foundational technology to develop rapid and quantitative diagnostics tests for different biomarkers using Quantum Dots. The quantitative features as well as the accuracy levels of our tests make them ideal for immunity level detection, biomarker monitoring in drug development, infectious diseases management through population studies for predictive models, and  biomarkers trends monitoring for personal health.


We are developing a companion secured and encrypted data platform for our Quantum Dot diagnostics. Numerical data from test results will be organized and managed to allow people to monitor trends of biomarkers associated with their health concerns, anonymized positive or negative population data for infectious diseases management, and monitor biomarkers to accelerate drug development for pharmaceutical companies.


We are partnering with several companies who bring novel drug delivery systems that will benefit from our Quantum Dot diagnostics technology and our data platform to participate in population studies that we are spearheading to create predictive models for infectious diseases.  We are helping in the formulation of  new drugs with potential increases in the bioavailability of beneficial APIs while substantially reducing toxicity and side effects.